Executive Director Controller

Executive Director Controller page is loaded## Executive Director Controller locations:
MA
- Waltham
- Office time type:
Full time posted on:
Posted Yesterday job requisition :
JR 000695

Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease that can progress to cirrhosis, liver failure, need for liver transplantation and premature mortality. Every member of our Madrigal team is connected by our shared purpose: leading the fight against MASH. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH.

Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c). Our success is driven by our people. We are building a dynamic, inclusive, and high-performing culture that values scientific excellence, operational rigor, and collaboration.

To support our continued growth, we are strengthening our workforce strategy to ensure we have the right talent, at the right time, in the right way.

The Executive Director, Corporate Controller, is a key finance leader responsible for core accounting operations ensuring accuracy, compliance with U.S. GAAP, delivering timely financial and statutory reporting. This strategic, yet hands-on role, will report to the Chief Accounting Officer working closely with peers, cross-functional executives, corporate enabling functions, and key external partners.

The Corporate Controller leads the close process, compliance with regulatory requirements, drives optimization of financial systems, and implements process improvements to enhance efficiency, strengthens internal controls, and supports risk management.

We are seeking leaders that are results-oriented, highly organized, and able to prioritize key initiatives, with strong attention to detail and dedication to quality and timely execution. They should be an effective communicator with strong interpersonal skills and have the ability to flex their management style, possess a “can do” attitude and a continuous improvement mindset to evolve the function’s capabilities, processes, and technologies to enable business priorities.

The successful candidate will have a strong background in accounting and finance, excellent leadership skills, and the ability to work collaboratively with global cross-functional teams.
** Responsibilities
* * Manage the day-to-day operations of the accounting department to support the needs of a publicly traded company, including timely and accurate month-end, quarter-end, and year-end close processes and compliance with regulatory requirements (i.e. SEC filings, statutory financial statements etc.). Collaborate with various internal and external partners, including non-finance operating teams, to provide financial data timely, share relevant insights and strategic recommendations to senior management and cross functional stakeholders.

Key areas of oversight include revenue recognition (gross to net accounting), general ledger, cost of goods sold (COGS), clinical trial accruals, payroll, travel and expense, and accounts payable.  Specifically:
* Oversee revenue accounting in compliance with ASC 606, gross to net accounting and government pricing calculations and compliance.
* Partner with supply chain teams to ensure accurate COGS reporting and inventory valuation.
* Direct the collaboration with R&D FP&A partners to ensure accurate and timely accruals for clinical studies and R&D activities.

Maintain, update and create global accounting policies and position papers to support US GAAP; review that underlying processes, systems and the broader control environment to support compliance with global accounting policies and other regulatory requirements.

Collaborate with technical accounting team to review complex accounting transactions, proposed accounting treatments and approach to operationalize policies;…